Cepheid Reports 2009 Third Quart... ( SUNNYVALE Calif. Oct. 28 /- Cepheid (...)

Cepheid Reports 2009 Third Quarter Results

Date:10/28/2009

SUNNYVALE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the third quarter of 2009 of $41.6 million. Net loss was $3.8 million, or $(0.07) per share, which compares to revenue of $44.9 million and a net loss of $6.6 million, or $(0.12) per share, in the third quarter of 2008.

Excluding amortization of purchased intangible assets and stock compensation expense, non-GAAP net loss for the third quarter was $0.1 million, or $(0.00) per share. This compares to a non-GAAP net loss of $2.5 million, or $(0.04) per share, in the third quarter of 2008.

"Cepheid continued to deliver against its aggressive development pipeline during the third quarter, with the commercial release of our high-throughput GeneXpert® Infinity-48 System, our Xpert® test for Clostridium difficile, and our Xpert test for HemosIL Factor II and Factor V," said John Bishop, Cepheid's Chief Executive Officer. "With our broadest test menu and system offering to date, Cepheid is defining the meaning of molecular diagnostics for labs of all sizes. This is highlighted by the rapid expansion of our Clinical Reagent business that is in a large part driven by continued adoption among our expanding GeneXpert system installed base of more than 1200 systems globally."

Operational Overview

Total product sales of $40.8 million in the third quarter of 2009, compared to $42.4 million in the third quarter of 2008. By industry, product sales were, in millions:

Three Months Ended
September 30,
2009 2008 Change
---- ----- ------
Clinical Systems $5.8 $10.7 -46%
Clinical Reagents 24.1 1
'/>"/>
SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved
0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine technology :

1. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
2. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
3. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
7. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
10. Endologix Reports 47% Third Quarter 2009 Revenue Growth
11. PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results

Post Your Comments:

(Date:7/10/2014)... July 10, 2014 Ventana Medical Systems, Inc. ... it has entered into an agreement with Merck KGaA, ... EMD Serono in the United States ... with Merck KGaA,s biopharmaceutical division on the development and ... target using Ventana,s proprietary diagnostic assays. In alignment with ...

(Date:7/10/2014)... , July 10, 2014 Decision Resources ... awareness of the U.S. Food and Drug Administration,s (FDA) ... phosphate binder Velphoro, which was approved by the FDA ... chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 : ...

(Date:1/15/2014)... Jan. 15, 2014 Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... used on patients in order to treat dental impairments, ...

Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2 Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3 Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2 Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3 Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2 Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3

[0] Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment [0] Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis [0] Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018

... N.Y. , July 6 E. Fougera & ... first generic approval from the FDA for Adapalene Cream 0.1% ... to Differin® by Galderma Pharmaceuticals. According to industry data, U.S. ... $55 million . This approval also marks the fourth product ...

... PARSIPPANY, N.J. , July 6 July 5th is ... in the state of Wisconsin and every year almost 7,200 of them ... an added incentive to quit with the Wisconsin smoke free law that ... , , ...

Cached Medicine Technology:Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin® 2 Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin® 3 Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 2 Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 3

Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin®Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit

(Date:7/14/2014)... EurekaMag.com has newly published results of ... contagious liver disease that ranges in severity from ... serious, lifelong illness that attacks the liver. An estimated ... Hepatitis C virus infection of which approximately 80% of ... category covers all studies on Hepatitis C , the ...

(Date:7/14/2014)... "Medical devices, tests, and treatments are critical ... is a star when it comes to innovations in ... working on amazing products and ideas that are our ... to Dale Kaye CEO of the Innovation Tri-Valley ... brilliant minds and businesses that are leading society into ...

(Date:7/14/2014)... WI (PRWEB) July 14, 2014 Doctor ... announced the launch of their new company website. The ... valuable free information on chiropractic marketing. It's also a ... that Inception has to offer. , When contacted at ... the newest version of our main website. Our site ...

(Date:7/14/2014)... Essex, CT (PRWEB) July 14, 2014 Summer ... means vacations, camping, days at the beach, swimming and other ... want everyone to be safe, happy and healthy all summer ... of a list of the three must-have custom imprinted products ... first summer essential is of course sunblock. Sunscreen ...

(Date:7/13/2014)... 2014 Save the Date for the 2014 ... Jacksonville, FL , BOXWOODS & BowTies “A Modern Twist on ... The Women’s Board of Wolfson Children’s Hospital will ... to continue their ongoing commitment to raising funds for the ... , What: The 2014 Art & Antiques Show is a ...

[0] EurekaMag.com Publishes 64,900 New Studies on Hepatitis C [0] Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators [0] Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website [0] Why These Three Summer Essentials from 4AllPromos Can Improve Summer [0] Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL

... 21 LUMEDX Corporation, a leading,provider of ... introduces software to manage data and track ... Module empowers clinicians,by making critical clinical information ... For more information -- including a free ...

... May 20 The U.S. Department of,Health and ... advertising,campaign focusing on the quality of care available ... HHS, Centers for Medicare & Medicaid Services (CMS),in ... newspapers, promote Hospital,Compare ( http://www.hospitalcompare.hhs.gov ), an easy-to-use ...

... researchers,found that the frequency with which critically-ill patients ... a,multidisciplinary medical center such as Mayo Clinic compared ... the National Healthcare Safety,Network (NHSN). This is good ... are generally strong across the U.S. in intensive ...

... 2008) A newly published study presents data ... (COPD), including emphysema and chronic bronchitis, experienced markedly ... a combination of nebulized formoterol fumarate inhalation solution ... treatment with tiotropium alone. The two medications, ...

... BEDFORD, Mass., May 20 Hologic, Inc. (Nasdaq:,HOLX) today ... at the NASDAQ 21st Investor Program being held May ... parties are invited to listen to a live audio ... at 10:45 a.m.,BST on the investor section of the ...

... One of 35,000 Doctors Now Using E-Prescribing, ... (PCMA) is unveiling a new print ad campaign ... successfully use electronic,prescribing (e-prescribing) technology and who also ... new ad features Dr. R. David Allard, a ...

Cached Medicine News:Health News:New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety 2 Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 2 Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 3 Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 2 Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 3 Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 2 Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 3 Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 4 Health News:PCMA's New Ad Campaign: E-Prescribing is Ready Now 2

New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD Hologic to Present at NASDAQ's 21st Investor Program in London PCMA's New Ad Campaign: E-Prescribing is Ready Now

... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...

10L...

... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...

... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...

Medicine Products:

SoftGrip 5 L Fixed Volume Pipette Ovation BioNatural Pipette, two-stroke, fixed volume, 10L Finnpipette Fixed Volume, 10ul Eppendorf Reference Series 2000 Fixed-volume Pipette, 10 l